Methylphenidate in ADDH and Epilepsy
Abstract
The safety of methylphenidate (MPH), 0.3 mg/kg, in 9 boys and 8 girls, ages 6 to 16 years, with ADHD and epilepsy, studied in Jerusalem, Israel, was reported at the Annual Meeting of the Child Neurology Society, Oct 2-8, 1994, in San Francisco, CA.
DOI: https://doi.org/10.15844/pedneurbriefs-8-10-3 | Journal eISSN: 2166-6482
Language: English
Page range: 74 - 75
Published on: Oct 1, 1994
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 1994 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.